Johns Hopkins Children’s Center Researchers Report Potential New Treatment Regimens for Multidrug-Resistant TB Meningitis

In a preliminary study with a small number of humans, rabbits and mice, researchers at Johns Hopkins Children’s Center say they have developed four new regimens that have the potential to treat and save the lives of people with multidrug-resistant (MDR) tuberculous (TB) meningitis.